文献速递间质性肺疾病

共生口腔微生物群与纤维化肺疾病的疾病严重程度及死亡率

Commensal Oral Microbiota, Disease Severity, and Mortality in Fibrotic Lung Disease.
PubMed 文献 · Am J Respir Crit Care Med · 2024-01-01

该研究分析了511例IPF患者颊拭子的16S rRNA基因和鸟枪法宏基因组测序数据,发现颊部微生物多样性越高与基线FVC越低相关,且与死亡风险增加相关;而链球菌属比例越高与FVC较高及死亡风险降低相关,该属主要为缓症链球菌。

要点

  • 颊部微生物多样性增高与IPF患者基线FVC降低及死亡风险增加独立相关。
  • 颊部链球菌属比例增高与IPF患者FVC较高及死亡风险降低相关。
  • 链球菌属主要由缓症链球菌组成,其与肺功能保留和生存改善相关。

核心结论

  • 颊部微生物多样性增加可预测IPF疾病严重程度和死亡。
  • 口腔共生缓症链球菌与肺功能保留及生存改善相关。

研究设计与样本

  • 多中心CleanUP-IPF试验中511例IPF患者的颊拭子16S rRNA基因和鸟枪法宏基因组测序分析。
  • 颊拭子来自常规治疗和抗菌治疗队列,微生物组数据与疾病严重程度指标进行相关分析。

主要发现

  • 颊部微生物多样性每增加1单位,基线FVC平均差异为-3.60(95%CI -5.92至-1.29)%预计值。
  • 颊部链球菌属比例每增加10%,FVC平均差异为0.80(95%CI 0.16至1.43)%预计值(n=490)。
  • 微生物多样性增高与死亡风险增加相关(HR 1.73;95%CI 1.03-2.90)。
  • 链球菌属比例增高与死亡风险降低相关(HR 0.85;95%CI 0.73-0.99)。
  • 链球菌属主要由缓症链球菌组成。

临床怎么用

  • 颊部微生物组特征或可作为IPF疾病严重程度和预后的无创生物标志物。
  • 关注口腔共生菌群,尤其是缓症链球菌,可能为IPF管理提供新思路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Oral microbiota associate with diseases of the mouth and serve as a source of lung microbiota. However, the role of oral microbiota in lung disease is unknown. Objectives: To determine associations between oral microbiota and disease severity and death in idiopathic pulmonary fibrosis (IPF). Methods: We analyzed 16S rRNA gene and shotgun metagenomic sequencing data of buccal swabs from 511 patients with IPF in the multicenter CleanUP-IPF (Study of Clinical Efficacy of Antimicrobial Therapy Strategy Using Pragmatic Design in IPF) trial. Buccal swabs were collected from usual care and antimicrobial cohorts. Microbiome data were correlated with measures of disease severity using principal component analysis and linear regression models. Associations between the buccal microbiome and mortality were determined using Cox additive models, Kaplan-Meier analysis, and Cox proportional hazards models. Measurements and Main Results: Greater buccal microbial diversity associated with lower FVC at baseline (mean difference, -3.60; 95% confidence interval [CI], -5.92 to -1.29% predicted FVC per 1-unit increment). The buccal proportion of Streptococcus correlated positively with FVC (mean difference, 0.80; 95% CI, 0.16 to 1.43% predicted per 10% increase) (n = 490). Greater microbial diversity was associated with an increased risk of death (hazard ratio, 1.73; 95% CI, 1.03-2.90), whereas a greater proportion of Streptococcus was associated with a reduced risk of death (HR, 0.85; 95% CI, 0.73 to 0.99). The Streptococcus genus was mainly composed of Streptococcus mitis species. Conclusions: Increasing buccal microbial diversity predicts disease severity and death in IPF. The oral commensal S. mitis spp associates with preserved lung function and improved survival.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. O'Dwyer DN, Kim JS, Ma SF, et al. Commensal Oral Microbiota, Disease Severity, and Mortality in Fibrotic Lung Disease. Am J Respir Crit Care Med. 2024. PMID: 38051927. doi:10.1164/rccm.202308-1357OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。